Rebel Medicine
Series A in 2025
Rebel Medicine is a preclinical-stage life sciences company focused on developing innovative solutions for opioid-free pain management. The company specializes in injectable, long-acting local anesthetic formulations designed to provide 96 to 120 hours of effective analgesia following surgical procedures, thereby reducing reliance on opioids. Additionally, Rebel Medicine is developing anesthetic wound dressings aimed at alleviating pain from dermal injuries. By leveraging advanced drug delivery science, the company also offers a shear-thinning gel that can accommodate various active pharmaceutical ingredients, including small molecules and peptide therapies. This approach empowers pharmaceutical companies to enhance the effectiveness of existing pain management drugs while maintaining cost efficiency.
IsoTalent
Seed Round in 2022
IsoTalent is a full-service recruiting agency based in Lehi, Utah, specializing in providing global on-demand hiring solutions. The company offers personalized recruitment services at affordable hourly rates, ensuring high-touch collaboration with a team of professional recruiters. IsoTalent employs advanced technology for applicant tracking and screening, allowing clients to manage their human capital effectively. The agency focuses on enabling businesses to scale internationally while increasing team retention through viable and cost-effective hiring practices.
TellBio
Venture Round in 2021
TellBio is a biotechnology company focused on the treatment of cancer. It specializes in the detection, monitoring, management, and treatment of the disease through its innovative circulating tumor cells (CTCs) technology. This proprietary platform allows healthcare professionals to effectively detect and monitor the progression of cancer by analyzing tumor cells. By integrating advanced technology with therapeutic solutions, TellBio aims to enhance the capabilities of cancer treatment, ultimately improving patient outcomes and providing valuable insights into the disease.
Kyte Learning Solutions
Series A in 2014
Kyte Learning Solutions specializes in providing personalized learning services for educational institutions. The company offers a dynamic learning environment supported by a comprehensive video library of relevant educational technology training materials. Expert educators design experience-based training courses that focus on both technical skills and effective classroom application strategies. Administrators can assign and track courses, as well as evaluate data, enabling them to understand the professional development activities of their teachers. This capability helps educators acquire the necessary technological skills to achieve school objectives.
iSchool Campus
Venture Round in 2012
iSchool Campus is a forward-thinking Smart School provider based in Utah and Washington D.C. that focuses on enhancing the educational experience for both students and teachers. The company designs and constructs collaborative learning environments integrated with modern technology to foster innovation and creativity in classrooms. iSchool Campus offers a digital learning platform that provides students with full-time access to educational resources and technology. In addition, the platform includes development programs that train and certify teachers, IT administrators, and other school personnel. iSchool is dedicated to equipping educational institutions with the necessary tools and support to advance learning and effectively prepare students for the challenges of the 21st century.
Merrimack Pharmaceuticals
Private Equity Round in 2011
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 1993. The company focuses on discovering, designing, and developing innovative therapies for the treatment of diseases, particularly in the fields of autoimmunity and cancer. Merrimack employs a systems biology approach that utilizes multidisciplinary capabilities to create functional and predictive computational models of biological systems, including cell signaling networks. By combining novel therapeutics with diagnostics, the company aims to enhance treatment efficacy and outcomes. Additionally, Merrimack engages in third-party agreements to facilitate the processing and commercialization of its products.
TMJ Medical
Acquisition in 2010
TMJ Implants (Golden, CO USA), is the recognized world leader in the design and manufacture of alloplastic implants for the treatment of temporomandibular joint disorders and injuries. The company designs and manufactures both stock and custom devices for partial and total joint replacement.